ORIGINAL ARTICLE PURPOSE We aimed to investigate the potentiality of atelocollagen, a new embolic agent which is collagen type I in a porcine experimental model.
C
ollagen, the most abundant protein in the human body, is a vital component of the extracellular matrix and connective tissue, including blood vessels. Twenty-nine types of collagen have been identified, seven of which (types I-III, V, XI, XXIV, and XXVII) are fibrillar and assemble as stable triple helices, which then form a complex higher order three-dimensional fibrous superstructure (1) (2) . Collagen functions in activating platelets through binding the von Willebrand factor and platelet derived collagen receptors (3).
Recent reports have described the use of collagen as an arterial puncture closer device, and treatment for postcatheterization pseudoaneurysm and distal coronary artery perforation (4) (5) (6) . Collagen has also been used as an embolic material to occlude the intentional vessels in clinical and experimental studies (7) (8) (9) (10) (11) (12) (13) . Most of these previous reports involve microfibrillar collagen, which is characteristic with long fiber.
The aim of this study was to investigate the efficacy and effects, in terms of tissue permeability, histological changes, and blood flow changes, of hepatic or renal arterial embolization with atelocollagen, which is collagen type I, in a porcine experimental model.
Materials and methods

Procedures
This study protocol was approved by the Institutional Animal Experimental Committee. Three female pigs, each weighing 33 kg, were included in this study. All procedures were performed under general anesthesia. Animals were placed supine, and general anesthesia was administered with an intramuscular injection of ketamine hydrochloride (5 mg/kg Ketalar Intramuscular 500 mg, Daiichi Sankyo, Tokyo, Japan) and medetomidine chloride (80 µg/kg Domitor, Zenoaq, Fukushima, Japan), and maintained with administration of halothane (4% Fluothane, Takeda Pharmaceutical, Osaka, Japan) using a mask. After anesthetic administration, an endotracheal tube was inserted and anesthesia was maintained with halothane (1.5%), nitrous oxide (1.5 L/min), and oxygen (1.5 L/min). Electrocardiography was used to monitor heart rate and rhythm. Oxygen saturation and real-time blood pressure were monitored using a pulse oxymeter (BP-608V, OmronColin, Tokyo, Japan). Vascular sheaths (6 F and 7 F) were inserted into the femoral artery and carotid artery, respectively. A subtraction angiography system (Allura Xper FD20, Philips, Eindhoven, Holland) was used to perform the procedure, and antibiotics were continuously administered throughout the study. After catheterization of bilateral renal arteries, blood flow was measured using FloWire (Volcano Japan, Tokyo, Japan) before and after the procedure. Next, selective catheterization of the lower branch of the renal artery was performed with a 4 F catheter (C2, Hanako, Saitama, Japan). Collagen type I (3% Koken atelocollagen implant, Tokyo, Japan) ( Fig. 1) was injected through the catheter until blood flow stasis was achieved in the lower branch of the renal artery. Repeated renal angiograms were performed (iopamidol 300, Oypalomin 300, Konica Minolta, Tokyo, Japan) at an injection rate of 3 mL/s, with a total injection volume of 6 mL before and after this procedure to check occlusion of the lower pole of renal arteries. A celiac angiogram was performed with a 4 F catheter (C2, Hanako) and sequential hepatic arterial embolization with atelocollagen through the catheter until the blood flow stasis was achieved in the hepatic artery. Repeated celiac angiogram (iopamidol 300, Oypalomin 300, Konica Minolta, Tokyo, Japan), at an injection rate of 4 mL/s with a total injection volume of 8 mL, was performed.
Histological evaluation
After renal embolization, animals were euthanized on the day of study, approximately two hours after transcatheter arterial embolization. Embolized organs were immediately harvested and immersed in buffered 3% formalin liquid fixation for seven days. Specimen samples were cut from paraffin blocks and examined using hematoxylin-eosin (H-E) staining. A pathologist (M.H.) evaluated the pathological slides according to the following considerations: 1) to determine in which periphery levels of the renal arteries the embolic materials were present, and 2) to assess changes of tissue around the renal arteries. Examination was performed with a Nikon Eclipse 80i (Nikon, Tokyo, Japan) and Nikon NIS-elements documentation ver. 3.22 (Nikon).
Results
Six lower interlobular renal arteries and three hepatic arteries were successfully embolized by administration of 0.8±0.3 mL and 2.9±1.2 mL, respectively, of collage type I (Figs. 2, 3) .
Histological findings of the embolized vessels are shown in Tables 1 and 2 . Histological analysis of kidneys showed that the collagenous materials filled arteriole lumens from 2.02 to 839.82 µm in diameter, and reached the level of afferent arterioles of glomerular tufts (Fig. 2) . In the liver, collagenous materials filled arteriole lumens from 2.81 to 187.86 µm in diameter (Fig. 3) . No necrotic areas were found in the arterial walls in either organ.
The renal and celiac arterial velocity and flow changed significantly after embolization. In the renal artery group, the maximum peak systolic velocity decreased immediately after embolization (38.6 cm/s vs. 16.7 cm/s, respectively), while an increase was detected in the celiac artery group (31 cm/s vs. 51.3 cm/s, respectively).
Discussion
Atelocollagen is a nearly purified form of type I collagen that lacks high antigenicity, as the non-coil region has been removed by protease treatment (14) . It is in liquid form at low temperature, and forms a gel at 37°C (14) . Therefore, atelocollagen seems to be a more ideal embolic agent compared to microfibrillar collagen and gelatin sponge.
The concentration of collagen affects the injectability through a needle (15) reported that both 3% and 4% (w/v) collagen suspensions were acceptable concentration levels with respect to the force used (<50 N). In our study, we used a 3% atelocollagen suspension. In our experience with the suspension, we found 3% atelocollagen difficult to inject through a 2 F microcatheter. Therefore, we chose a 4 F diagnostic catheter to inject the 3% atelocollagen without resistance. Although this was an acute study (animals were sacrificed on the same day of the study), atelocollagen filled not only the main arterioles but also glomerular tufts of the kidney or distal peribiliary hepatic arteries. In addition, there were no changes in inflammation around the hepatic and renal arterioles. In contrast to our results, a previous experimental study using microfibrillar collagen reported granulomatous arteritis (7). However, another study using purified type I bovine tendon collagen showed that it filled arterioles of the kidney with no apparent inflammation around the arterial walls (16) . These findings are consistent with those of our study. It is worth noting that this study was performed under laparotomy and direct cannulation into the renal arteries, therefore the method of embolization differs from the transcatheter arterial embolization technique in our study.
In a flow dynamics study after transcatheter arterial embolization (TAE) for hepatocellular carcinoma the peak velocity (PV) of the proximal right hepatic artery (RHA) decreased immediately after TAE of RHA, probably due to the block of the RHA by embolization (17) . The authors proposed the possibility that the increased resistance caused the decrease of PV of proximal RHA. In our study, the PV of the renal artery decreased after TAE, but the PV of the celiac artery increased. The reason for this increase could be due to the position of the FloWire tip, which was in the celiac trunk proximal to the branching of the hepatic artery, splenic artery, and gastroepiploic artery. It is likely that the buffer effect after TAE of the hepatic artery could decrease resistance of the celiac artery.
There were some limitations in our study. First, our study was not a follow-up study and did not assess changes of embolized organs over time. Second, we were unable to visualize atelocolla- gen when embolization was performed under fluoroscopy, as we did not mix it with contrast medium in order to preserve its natural viscosity.
In conclusion, atelocollagen shows potential as an ideal embolic agent because of its low antigenicity, embolus formation in a wide range of size, and lack of inflammatory response.
